A Randomized Controlled Trial of a Behavioral Weight Loss Program for Human Immunodeficiency Virus-Infected Patients.
- Resource Type
- Article
- Authors
- Becofsky, Katie; Wing, Edward J.; McCaffery, Jeanne; Boudreau, Matthew; Wing, Rena R.
- Source
- Clinical Infectious Diseases. Jul2017, Vol. 65 Issue 1, p154-157. 4p.
- Subject
- *OBESITY complications
*HIV infection risk factors
*OBESITY treatment
*HIV infection transmission
*WEIGHT loss
*PHYSIOLOGY
- Language
- ISSN
- 1058-4838
Obesity compounds the negative health effects of human immunodeficiency virus (HIV) infection. We conducted the first randomized trial of behavioral weight loss for HIV-infected patients (n = 40). Participants randomized to an Internet behavioral weight loss program had greater 12-week weight loss (mean, 4.4 ± 5.4 kg vs 1.0 ± 3.3 kg; P = .02) and improvements in quality of life than controls. [ABSTRACT FROM AUTHOR]